Delisting riskPopularity #4,592
TCRT · NASDAQ · Biotechnology

Alaunos Therapeutics (TCRT)

Preclinical developer of ALN1003, an oral small molecule for obesity.

$1.13
vs last close−0.14 (−11.02%)